Christopher Flint OBrien, Chief Medical Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 3,500 shares at $43.35 ($152K) on 2017-01-10, disclosed to the SEC on 2017-01-12.
Seasonal sale ($152k) by Chief Medical Officer — this insider has traded NBIX in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $43.35 | 1,750 | $76K | 50.0% |
| 2 | $43.35 | 1,750 | $76K | 50.0% |
| Total | $43.35 avg | 3,500 | $152K | 100% |
| Filing → |
| NBIX | SELL | 2017-11-06 | $7.4M | — | Filing → |
| NBIX | SELL | 2017-10-03 | $423K | — | Filing → |
| NBIX | SELL | 2017-09-07 | $6.1M | — | Filing → |